These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9678779)
1. Vasculopathy and insulin resistance in the JCR:LA-cp rat. Richardson M; Schmidt AM; Graham SE; Achen B; DeReske M; Russell JC Atherosclerosis; 1998 May; 138(1):135-46. PubMed ID: 9678779 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease in the JCR:LA-cp rat. Russell JC; Graham SE; Richardson M Mol Cell Biochem; 1998 Nov; 188(1-2):113-26. PubMed ID: 9823017 [TBL] [Abstract][Full Text] [Related]
3. Chelation therapy in the JCR:LA-cp rat: experimental assessment of a putative antiatherosclerotic treatment. O'Brien SF; Kelly SE; Dolphin PJ; Russell JC Clin Invest Med; 2000 Apr; 23(2):124-31. PubMed ID: 10852662 [TBL] [Abstract][Full Text] [Related]
4. Improvement of insulin sensitivity and cardiovascular outcomes in the JCR:LA-cp rat by D-fenfluramine. Russell JC; Dolphin PJ; Graham SE; Amy RM; Brindley DN Diabetologia; 1998 Apr; 41(4):380-9. PubMed ID: 9562341 [TBL] [Abstract][Full Text] [Related]
5. Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Russell JC; Shillabeer G; Bar-Tana J; Lau DC; Richardson M; Wenzel LM; Graham SE; Dolphin PJ Diabetes; 1998 May; 47(5):770-8. PubMed ID: 9588449 [TBL] [Abstract][Full Text] [Related]
6. Antiatherogenic effects of long-term benfluorex treatment in male insulin resistant JCR:LA-cp rats. Russell JC; Graham SE; Dolphin PJ; Amy RM; Wood GO; Brindley DN Atherosclerosis; 1997 Jul; 132(2):187-97. PubMed ID: 9242964 [TBL] [Abstract][Full Text] [Related]
7. Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099). Russell JC; Graham SE; Dolphin PJ Metabolism; 1999 Jun; 48(6):701-6. PubMed ID: 10381143 [TBL] [Abstract][Full Text] [Related]
8. The retardation of vasculopathy induced by attenuation of insulin resistance in the corpulent JCR:LA-cp rat is reflected by decreased vascular smooth muscle cell proliferation in vivo. Absher PM; Schneider DJ; Baldor LC; Russell JC; Sobel BE Atherosclerosis; 1999 Apr; 143(2):245-51. PubMed ID: 10217352 [TBL] [Abstract][Full Text] [Related]
9. Cardioprotective and hypolipidemic effects of nisoldipine in the JCR:LA-cp rat. Russell JC; Dolphin PJ; Graham SE; Amy RM J Cardiovasc Pharmacol; 1997 May; 29(5):586-92. PubMed ID: 9213199 [TBL] [Abstract][Full Text] [Related]
10. Beneficial insulin-sensitizing and vascular effects of S15261 in the insulin-resistant JCR:LA-cp rat. Russell JC; Ravel D; Pégorier JP; Delrat P; Jochemsen R; O'Brien SF; Kelly SE; Davidge ST; Brindley DN J Pharmacol Exp Ther; 2000 Nov; 295(2):753-60. PubMed ID: 11046115 [TBL] [Abstract][Full Text] [Related]
11. Vascular dysfunction and myocardial contractility in the JCR:LA-corpulent rat. Brunner F; Wölkart G; Pfeiffer S; Russell JC; Wascher TC Cardiovasc Res; 2000 Jul; 47(1):150-8. PubMed ID: 10869541 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the enteroinsular axis in two strains of obese rat, the fatty Zucker and the JCR:LA-corpulent. Pederson RA; Campos RV; Buchan AM; Chisholm CB; Russell JC; Brown JC Int J Obes; 1991 Jul; 15(7):461-70. PubMed ID: 1894423 [TBL] [Abstract][Full Text] [Related]
13. Vascular wall reactivity in conductance and resistance arteries: differential effects of insulin resistance. O'Brien SF; McKendrick JD; Radomski MW; Davidge ST; Russell JC Can J Physiol Pharmacol; 1998 Jan; 76(1):72-6. PubMed ID: 9564552 [TBL] [Abstract][Full Text] [Related]
14. MEDICA 16 inhibits hepatic acetyl-CoA carboxylase and reduces plasma triacylglycerol levels in insulin-resistant JCR: LA-cp rats. Atkinson LL; Kelly SE; Russell JC; Bar-Tana J; Lopaschuk GD Diabetes; 2002 May; 51(5):1548-55. PubMed ID: 11978655 [TBL] [Abstract][Full Text] [Related]
15. Vascular wall dysfunction in JCR:LA-cp rats: effects of age and insulin resistance. O'brien SF; Russell JC; Davidge ST Am J Physiol; 1999 Nov; 277(5):C987-93. PubMed ID: 10564092 [TBL] [Abstract][Full Text] [Related]
16. Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats. Wascher TC; Wölkart G; Russell JC; Brunner F Diabetes; 2000 May; 49(5):803-9. PubMed ID: 10905490 [TBL] [Abstract][Full Text] [Related]
17. Developmental changes in adipose and muscle lipoprotein lipase activity in the atherosclerosis-prone JCR:LA-corpulent rat. Mantha L; Russell JC; Brindley DN; Deshaies Y Int J Obes Relat Metab Disord; 2002 Mar; 26(3):308-17. PubMed ID: 11896485 [TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of a novel silicate inositol complex of the nitric oxide precursor arginine in the obese insulin-resistant JCR:LA-cp rat. Proctor SD; Kelly SE; Vine DF; Russell JC Metabolism; 2007 Oct; 56(10):1318-25. PubMed ID: 17884439 [TBL] [Abstract][Full Text] [Related]
19. Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome. Vine DF; Takechi R; Russell JC; Proctor SD Atherosclerosis; 2007 Feb; 190(2):282-90. PubMed ID: 16624317 [TBL] [Abstract][Full Text] [Related]
20. Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA- cp rat model of the metabolic syndrome. Lu J; Borthwick F; Hassanali Z; Wang Y; Mangat R; Ruth M; Shi D; Jaeschke A; Russell JC; Field CJ; Proctor SD; Vine DF Br J Nutr; 2011 Jun; 105(11):1572-82. PubMed ID: 21276281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]